Explore how pneumococcal vaccine efficacy is measured, its real-world impact, and the importance of immunobridging for informed vaccination decisions.
Back
Pneumococcal Insights: Data, Guidance, and Real-World Pharmacy Practice
This educational Insights video series equips pharmacists with the latest evidence and recommendations surrounding adult pneumococcal vaccination. Drawing on new clinical data, updated CDC Advisory Committee on Immunization Practices guidance, and evolving public health considerations, this series breaks down how pneumococcal vaccine efficacy is measured, how recent approvals were supported by immunobridging data, and what today’s serotype landscape means for patient care. It also provides practical strategies for integrating the expanded age-based recommendations for adults 50 and older into routine workflow, immunization screening, and patient counseling.
Pneumococcal Insights: Data, Guidance, and Real-World Pharmacy Practice
Episodes
All
All
Pharmacists adapt to new CDC guidelines, emphasizing pneumococcal vaccination for adults 50+, enhancing patient screening and vaccination efficiency.
Pharmacists enhance patient trust by addressing concerns, providing evidence-based guidance, and promoting vaccination through clear communication and follow-ups.
Pharmacists enhance pneumococcal vaccination integration through routine screenings, flexible access, and team-based approaches for improved patient care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Hypertension Guideline: Key Shifts for Pharmacists
2
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
3
Serologic Immunity to Hepatitis A and B Remains Low Among US Adults
4
The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question
5